Procyon Biopharma Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Procyon Biopharma Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: thebeach who wrote (237)	2/25/2000 8:37:00 AM
From: Jeff Chan	Read Replies (1) of 356

Re: Fibrostat... The Company was very actively pursuing negotiations with potential partners for the out-licensing of FIBROSTAT(TM) during the quarter, and has finalized an agreement for Canada. FIBROSTAT(TM) is Procyon's product for the management of scars resulting from surgery and/or burns and for potential use in a variety of dermatoses. The Company is also in serious negotiations for other jurisdictions This is kind of strange...Biovail has already picked up Fibrostat Jeff C

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next